BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1793453)

  • 1. International Commission for Protection Against Environmental Mutagens and Carcinogens. Report of ICPEMC Subcommittee 7/1. The possible involvement of somatic mutations in the development of atherosclerotic plaques.
    Atherosclerosis; 1991 Aug; 89(2-3):255-61. PubMed ID: 1793453
    [No Abstract]   [Full Text] [Related]  

  • 2. International Commission for Protection Against Environmental Mutagens and Carcinogens. The possible involvement of somatic mutations in the development of atherosclerotic plaques. Report of ICPEMC Subcommittee 7/1. Conclusions and recommendations.
    Mutat Res; 1990 Nov; 239(3):143-8. PubMed ID: 2233823
    [No Abstract]   [Full Text] [Related]  

  • 3. International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC Topic No. 1. Are somatic mutations involved in atherosclerosis?
    Bridges BA
    Mutat Res; 1987 Dec; 182(6):301-2. PubMed ID: 3683430
    [No Abstract]   [Full Text] [Related]  

  • 4. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC Working Paper 7/1/3. Animal studies suggesting involvement of mutagen/carcinogen exposure in atherosclerosis.
    Wakabayashi K
    Mutat Res; 1990 Nov; 239(3):181-7. PubMed ID: 2233825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC Working Paper 7/1/2. Shared risk factors for cancer and atherosclerosis--a review of the epidemiological evidence.
    Hansen ES
    Mutat Res; 1990 Nov; 239(3):163-79. PubMed ID: 2233824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International Commission for Protection Against Environmental Mutagens and Carcinogens. Spontaneous mutation and its place in risk assessment for chemical mutagens. Report of an ICPEMC Committee.
    Bridges BA; Cole J; Favor J; Glickman BW; Mohrenweiser H; Sankaranarayanan K; Skopek TR
    Mutat Res; 1994 Jan; 304(1):3-11. PubMed ID: 7506356
    [No Abstract]   [Full Text] [Related]  

  • 7. International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC Publication No. 15. Alcohol as a mutagenic agent. Report of an ICPEMC expert group.
    Mutat Res; 1987 Nov; 186(3):173-4. PubMed ID: 3670330
    [No Abstract]   [Full Text] [Related]  

  • 8. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC publication No. 16. Testing for mutagens and carcinogens; the role of short-term genotoxicity assays.
    Mutat Res; 1988; 205(1-4):3-12. PubMed ID: 3285192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC publication no. 6: do treatments available for psoriasis patients carry a genetic or carcinogenic risk?
    Mutat Res; 1981 May; 86(3):279-304. PubMed ID: 7029262
    [No Abstract]   [Full Text] [Related]  

  • 10. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC Publication No. 12. Inhibitors of mutagenesis and their relevance to carcinogenesis. Report by ICPEMC Expert Group on Antimutagens and Desmutagens.
    Ramel C; Alekperov UK; Ames BN; Kada T; Wattenberg LW
    Mutat Res; 1986 Jul; 168(1):47-65. PubMed ID: 3520303
    [No Abstract]   [Full Text] [Related]  

  • 11. The International Commission for Protection against Environmental Mutagens and Carcinogens (ICPEMC): the first seven years.
    Jansen JD
    Regul Toxicol Pharmacol; 1984 Jun; 4(2):138-44. PubMed ID: 6739865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC Working Paper 7/1/1. Mutational events in the etiology of arteriosclerotic plaques.
    Penn A
    Mutat Res; 1990 Nov; 239(3):149-62. PubMed ID: 2122242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC Meeting Report No. 2. Approaches to determining mutation rates in human DNA.
    Delehanty J; White RL; Mendelsohn ML
    Mutat Res; 1986 May; 167(3):215-32. PubMed ID: 2421159
    [No Abstract]   [Full Text] [Related]  

  • 14. International Commission for Protection against Environmental Mutagens and Carcinogens: ICPEMC news no. 2.
    Sobels FH
    Mutat Res; 1979 Oct; 64(5):357-61. PubMed ID: 514300
    [No Abstract]   [Full Text] [Related]  

  • 15. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC publication No. 18. Review of the genotoxicity and carcinogenicity of antischistosomal drugs; is there a case for a study of mutation epidemiology? Report of a task group on mutagenic antischistosomals.
    Kramers PG; Gentile JM; Gryseels BJ; Jordan P; Katz N; Mott KE; Mulvihill JJ; Seed JL; Frohberg H
    Mutat Res; 1991 Jan; 257(1):49-89. PubMed ID: 1987457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation epidemiology: review and recommendations. A report to the International Commission for Protection against Environmental Mutagens and Carcinogens by Committee 5 (Epidemiology).
    Mutat Res; 1983 Sep; 123(1):1-11. PubMed ID: 6888411
    [No Abstract]   [Full Text] [Related]  

  • 17. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC publication no. 14. Considerations for population monitoring using cytogenetic techniques.
    Carrano AV; Natarajan AT
    Mutat Res; 1988 Mar; 204(3):379-406. PubMed ID: 3347212
    [No Abstract]   [Full Text] [Related]  

  • 18. International Commission for Protection Against Environmental Mutagens and Carcinogens. Genotoxicity under extreme culture conditions. A report from ICPEMC Task Group 9.
    Scott D; Galloway SM; Marshall RR; Ishidate M; Brusick D; Ashby J; Myhr BC
    Mutat Res; 1991 Mar; 257(2):147-205. PubMed ID: 2005937
    [No Abstract]   [Full Text] [Related]  

  • 19. International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC publication no. 10. Review of the evidence for the presence or absence of thresholds in the induction of genetic effects by genotoxic chemicals.
    Ehling UH; Averbeck D; Cerutti PA; Friedman J; Greim H; Kolbye AC; Mendelsohn ML
    Mutat Res; 1983 Dec; 123(3):281-341. PubMed ID: 6646151
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of somatic mutation in atherosclerosis.
    Penn A
    Prog Clin Biol Res; 1990; 340C():93-100. PubMed ID: 2116623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.